Focus: Shoulder Innovations is a public biotechnology company headquartered in Grand Rapids, MI, specializing in shoulder replacement systems and orthopedic solutions. The company operates at a modest commercial scale with $32M in FY 2025 revenue.
Profile data last refreshed 12h ago · AI intelligence enriched 3w ago
Shoulder Innovations is a financially stressed, early-stage orthopedic device company with upside optionality but meaningful execution risk; suitable only for candidates with orthopedic domain expertise, high risk tolerance, and long-term commitment.
Help build intelligence for Shoulder Innovations
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Shoulder Innovations's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Shoulder Innovations Announces Closing of up to $50 Million Credit Facility - PR Newswire
Shoulder Innovations Announces Closing of up to $50 Million Credit Facility PR Newswire
Shoulder Innovations, Inc. Hits New 52-Week High of $19.72 - MarketsMojo
Shoulder Innovations, Inc. Hits New 52-Week High of $19.72 MarketsMojo
Shoulder Innovations, Inc. Hits New 52-Week High of $19.72 - MarketsMojo
Shoulder Innovations, Inc. Hits New 52-Week High of $19.72 MarketsMojo
Shoulder Innovations, Inc. Hits New 52-Week High of $19.30 - MarketsMojo
Shoulder Innovations, Inc. Hits New 52-Week High of $19.30 MarketsMojo
Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - Yahoo Finance
Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference Yahoo Finance
Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - PR Newswire
Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Effectiveness of stratified blended physiotherapy versus usual physiotherapy for neck and shoulder pain: a cluster-randomized trial.
Psychometric evaluation of the Persian version of the return-to-sport scale after shoulder instability in Iranian athletes.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo